Members |
targetComponentId |
Nonallopathic lesion, NEC |
Impaired or altered function of related components of the body framework system: skeletal, arthrodial and myofascial structures, and their related vascular, lymphatic and neural elements. It is characterized by positional asymmetry, restricted range of motion, tissue texture abnormalities, and/or tenderness. The positional and motion aspects of somatic dysfunction are generally described by: (1) The position of a body part as determined by palpation and referenced to its defined adjacent structure, (2) The directions in which motion is freer, and (3) The directions in which motion is restricted. Somatic dysfunction is treatable using osteopathic manipulative treatment. |
Nonbacterial gastroenteritis |
Infectious gastroenteritis |
Nondependent alcohol abuse NOS |
Nondependent harmful pattern of use of alcohol (disorder) |
Nondependent alcohol abuse, unspecified |
Nondependent harmful pattern of use of alcohol (disorder) |
Nondependent antidepressant type drug abuse NOS |
Harmful pattern of use of antidepressant |
Nondependent antidepressant type drug abuse in remission |
Nondependent harmful pattern of use of antidepressant in remission (disorder) |
Nondependent antidepressant type drug abuse, continuous |
Continuous nondependent harmful pattern of use of antidepressant (disorder) |
Nondependent antidepressant type drug abuse, episodic |
Episodic nondependent harmful pattern of use of antidepressant (disorder) |
Nondependent antidepressant type drug abuse, unspecified |
Harmful pattern of use of antidepressant |
Nondependent cannabis abuse NOS |
Nondependent harmful pattern of use of cannabis (disorder) |
Nondependent cannabis abuse, unspecified |
Nondependent harmful pattern of use of cannabis (disorder) |
Nondependent cocaine abuse NOS |
Nondependent harmful pattern of use of cocaine |
Nondependent cocaine abuse, unspecified |
Nondependent harmful pattern of use of cocaine |
Nondependent hallucinogen abuse NOS |
Nondependent harmful pattern of use of hallucinogen (disorder) |
Nondependent hallucinogen abuse, unspecified |
Nondependent harmful pattern of use of hallucinogen (disorder) |
Nondependent mixed drug abuse |
Nondependent harmful pattern of mixed substance use (disorder) |
Nondependent mixed drug abuse NOS |
Nondependent harmful pattern of mixed substance use (disorder) |
Nondependent mixed drug abuse in remission |
Nondependent harmful pattern of mixed substance use in remission (disorder) |
Nondependent mixed drug abuse, continuous |
Continuous nondependent harmful pattern of mixed substance use (disorder) |
Nondependent mixed drug abuse, episodic |
Episodic nondependent harmful pattern of mixed substance use (disorder) |
Nondependent mixed drug abuse, unspecified |
Nondependent harmful pattern of mixed substance use (disorder) |
Nondependent opioid abuse NOS |
Nondependent harmful pattern of use of opioid |
Nondependent opioid abuse, unspecified |
Nondependent harmful pattern of use of opioid |
Nondependent other drug abuse |
Nondependent harmful pattern of substance use |
Nondependent other drug abuse NOS |
Nondependent harmful pattern of substance use |
Nondependent other drug abuse in remission |
Nondependent harmful pattern of substance use in remission |
Nondependent other drug abuse, continuous |
Continuous nondependent harmful pattern of substance use (disorder) |
Nondependent other drug abuse, episodic |
Episodic nondependent harmful pattern of substance use (disorder) |
Nondependent other drug abuse, unspecified |
Nondependent harmful pattern of substance use |
Nonexudative senile macular retinal degeneration |
Nonexudative age-related macular degeneration (disorder) |
Noninfiltrating intracystic carcinoma |
Encapsulated papillary carcinoma (morphologic abnormality) |
Nonpyogenic thrombosis of intracranial venous sinus |
Nonpyogenic thrombosis of intracranial venous sinus |
Nonspecific abdominal symptom |
Finding of abdomen |
Nonspecific antibody |
Nonspecific immunoglobulin (substance) |
Nonspecific surgical approaches |
Procedural approach |
Nonstageable pressure ulcer |
Unstageable pressure injury |
Norepinephrine acid tartrate 2mg/mL infusion concentrate 20mL ampule |
Noradrenaline (as noradrenaline bitartrate) 1 mg/mL solution for injection |
Norepinephrine acid tartrate 2mg/mL infusion concentrate 2mL ampule |
Noradrenaline (as noradrenaline bitartrate) 1 mg/mL solution for injection |
Norfloxacin 0.3% solution |
Norfloxacin only product in ocular dose form |
Normal active range of ankle extension |
Normal active range of ankle plantar flexion (finding) |
Normal active range of ankle flexion |
Normal active range of ankle dorsiflexion |
Normal laboratory finding |
Measurement finding within reference range |
Normal passive range of ankle extension |
Normal passive range of ankle plantar flexion |
Normal passive range of ankle flexion |
Normal passive range of ankle dorsiflexion |
Normal periodontal tissue surrounding dental implant |
Normal oral mucous membrane and osseointegrated bone tissue surrounding dental implant (finding) |
Normal physical attitude |
Body posture normal |
Normal retraction of upper segment |
Normal retraction of upper uterine segment |
Normal saline |
Sodium chloride only product |
Normal saline + potassium chloride |
Product containing only potassium chloride and sodium chloride (medicinal product) |
Norman Miller operation on vagina |
Fixation of vagina |
Normosomatic sialidosis |
Sialidosis type 1 (ST-1) is a very rare lysosomal storage disease, and is the normosomatic form of sialidosis, characterized by gait abnormalities, progressive visual loss, bilateral macular cherry red spots and myoclonic epilepsy and ataxia, that usually presents in the second to third decade of life. |
North American blastomycosis |
Blastomycosis |
North American cutaneous blastomycosis |
Cutaneous blastomycosis |
North American disseminated blastomycosis |
Disseminated blastomycosis |
North American ocular blastomycosis |
Ocular blastomycosis (disorder) |
North American pulmonary blastomycosis |
Pulmonary blastomycosis |
North American urogenital blastomycosis |
Urogenital blastomycosis (disorder) |
Nortriptyline hydrochloride 50mg |
Nortriptyline (as nortriptyline hydrochloride) 50 mg oral capsule |
Nortriptyline hydrochloride 75mg |
Product containing precisely nortriptyline (as nortriptyline hydrochloride) 75 milligram/1 each conventional release oral capsule (clinical drug) |
Nose flap |
Flap (substance) |
Nose lesion excised NOS |
Nose lesion excised |
Nose lesion excised NOS |
Nose lesion excised |
Nosema cuniculi |
Encephalitozoon cuniculi |
Notification of disease NOS |
Notification of disease |
Notification of disease NOS |
Notification of disease |
Notifications NOS |
Notification status |
Notifications NOS |
Notifications |
Notornis mantelli |
Porphyrio mantelli (organism) |
Noxious fumes |
Fumes are fine, airborne, solid particles generated by condensation from the gaseous state, generally after volatilization from a melted substance (e.g. the high temperature chemical process during welding), and often accompanied by a chemical reaction such as oxidation. |
Noxious substance eaten as food causing toxic effect NOS |
Food poisoning (disorder) |
Noxythiolin 2.5g powder for reconstitution |
Product containing precisely noxytiolin 2.5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Nuchal |
Structure of posterior region of neck |
Nuclear magnetic resonance NOS |
Nuclear magnetic resonance measurement (procedure) |
Nuclear magnetic resonance NOS |
Nuclear magnetic resonance measurement (procedure) |
Nuclear medicine diagnostic procedure |
Nuclear medicine procedure (procedure) |
Nuclear medicine diagnostic procedure |
Nuclear medicine procedure (procedure) |
Nuclear medicine diagnostic procedure on endocrine system |
Radioisotope study of endocrine system |
Nuclear medicine diagnostic procedure on hematopoietic system |
Radioisotope study of hematopoietic system |
Nuclear medicine service |
Nuclear medicine service |
Nucleic acid detection |
Nucleic acid assay (procedure) |
Nucleic acid detection |
Nucleic acid assay (procedure) |
Nucleic acid detection |
Nucleic acid assay (procedure) |
Nucleosidase |
Nucleosidase |
Nucleotidyltransferase |
Nucleotidyltransferase |
Number of asthma exacerbations in past year |
Number of asthma exacerbations in past year |
Number of asthma exacerbations in past year |
Number of asthma exacerbations in past year |
Number of non-regional lymph nodes involved |
Number of lymph nodes containing metastatic neoplasm in excised specimen |
Number of previous induced termination of pregnancy |
Number of induced abortions (observable entity) |
Nurse for the mentally handicapped |
Intellectual disability nurse (occupation) |
Nursing care |
Nursing procedure |
Nursing care NOS |
Nursing procedure |
Nursing care NOS |
Nursing procedure |
Nursing care of episiotomy wound |
Episiotomy care |
Nursing care of newborn |
Newborn care service |
Nursing care of obstetrical laceration |
Obstetrical laceration care (regime/therapy) |
Nursing care planning session |
Care planning session |
Nursing consultation and report |
Consultation |
Nursing diagnosis |
Nursing diagnosis |
Nursing educational service |
Nursing procedure |
Nursing occupation NOS |
Nursing occupation (occupation) |
Nursing occupations NOS |
Nursing occupation (occupation) |